Akram Bouchenaki

Akram Bouchenaki is Chief Executive Officer of Abdul Latif Jameel Health, Abdul Latif Jameel’s health care business, focusing on accelerating access to modern medical care while addressing unmet medical needs in developing markets around the World.  Abdul Latif Jameel Health is part of Abdul Latif Jameel, a collective of independent international, family-owned and diversified businesses, founded in 1945 by the late Abdul Latif Jameel.

Mr. Bouchenaki joins Abdul Latif Jameel Health after 25 years of operational and strategic roles in the pharmaceutical and healthcare sectors, including global leadership roles in ‘big-pharma’ corporates as well as in top California-based biotech, where he was an executive director for Africa covering the largest markets on the continent.

Akram has extensive knowledge and experience of both generics and branded medicines in established as well as key emerging markets across the world.  These include Africa’s most significant markets, Brazil, and Mexico, having co-founded a fast-growing start-up to commercialize medicines in Latin America.

Akram holds a Doctorate in Pharmacy from Université de Paris V, France.  He has lived and worked in nine different countries across five continents. He speaks French, Spanish, Arabic, Portuguese and English.

Founded in 1945, Abdul Latif Jameel is a private family-owned global investor and diversified business that celebrated its 75th Anniversary in 2020.  Abdul Latif Jameel works across major industry sectors aiming to positively shape the future of core industries driving the global economy.  These include Investments; Mobility; Financial Services; Energy & Environmental Services: Health, and a diversified range of other operations from consumer products and property development to professional services.

With corporate representation offices around the globe, the business has an operational presence in more than 35 countries on six continents and employs more than 11,000 people of over 65 nationalities.